Tedesco Alexandra, Majumdar Monica, Ortoleva Jamel P, Nayar Christine, Kawabori Masashi, Salehi Payam, Irshad Ali
Department of General Surgery, Tufts Medical Center, Boston, MA.
Department of Anesthesia, Tufts Medical Center, Boston, MA.
J Vasc Surg Cases Innov Tech. 2023 Feb 10;9(2):101121. doi: 10.1016/j.jvscit.2023.101121. eCollection 2023 Jun.
Extracorporeal membrane oxygenation (ECMO) support for patients with cardiac or respiratory failure has been increasingly used by advanced critical care practitioners. The thromboembolic complications of ECMO have been extensively discussed and researched; however, research and discussion on the development, risks, and management of cannulae-associated fibrin sheaths are lacking.
Institutional review board approval was not required. We have presented three cases detailing the identification and individualized management of ECMO-associated fibrin sheaths at our institution. The three patients provided written informed consent for the report of their case details and imaging studies.
Of our three patients with ECMO-associated fibrin sheaths, two were managed successfully with anticoagulation alone. One could not receive anticoagulation therapy and underwent inferior vena cava filter placement.
Fibrin sheath formation around indwelling ECMO cannulae is an unresearched complication of ECMO cannulation. We would recommend an individualized approach to the management of these fibrin sheaths and have provided three examples of successful management.
体外膜肺氧合(ECMO)支持已越来越多地被高级重症监护从业者用于治疗心脏或呼吸衰竭患者。ECMO的血栓栓塞并发症已得到广泛讨论和研究;然而,关于与插管相关的纤维蛋白鞘的形成、风险及管理的研究和讨论却很缺乏。
无需机构审查委员会批准。我们展示了三例详细介绍在我们机构中对与ECMO相关的纤维蛋白鞘进行识别及个体化管理的病例。这三名患者均提供了书面知情同意书,同意报告其病例细节及影像学研究。
在我们三名患有与ECMO相关纤维蛋白鞘的患者中,两名仅通过抗凝治疗即成功治愈。一名患者无法接受抗凝治疗,因此接受了下腔静脉滤器植入术。
留置ECMO插管周围纤维蛋白鞘的形成是ECMO插管一种尚未得到研究的并发症。我们建议对这些纤维蛋白鞘采取个体化管理方法,并提供了三个成功管理的实例。